What is the market capitalization of Profound Medical Corp.?

Profound Medical Corp. (PROF) has a market capitalization of approximately 238,011,522 USD.

Where can I buy PROF in Canada?

PROF can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

PROF

Profound Medical Corp.

Profound Medical Corp. (PROF) is a Canadian company in the healthcare sector, listed on NASDAQ. Market capitalization of 238 million USD (micro-cap).

Details

Price6.55 USD

Market cap238.01 M USD

Payout ratio0.00%

ROE-70.59%

Debt / Equity12.56%

SectorHealthcare

Websiteprofoundmedical.com

Updated a few minutes ago

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.